Equities

NU Skin Enterprises Inc

NU Skin Enterprises Inc

Actions
  • Price (EUR)6.85
  • Today's Change-0.150 / -2.14%
  • Shares traded0.00
  • 1 Year change-56.37%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year NU Skin Enterprises Inc's revenues fell -11.53% from 2.23bn to 1.97bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 104.78m to 8.60m, a -91.80% decrease.
Gross margin70.70%
Net profit margin-5.81%
Operating margin-4.64%
Return on assets-6.11%
Return on equity-13.50%
Return on investment-7.93%
More ▼

Cash flow in USDView more

In 2023, NU Skin Enterprises Inc did not generate a significant amount of cash. However, the company earned 118.64m from its operations for a Cash Flow Margin of 6.02%. In addition the company generated 10.73m cash from financing while 134.50m was spent on investing.
Cash flow per share-0.6222
Price/Cash flow per share--
Book value per share14.22
Tangible book value per share10.50
More ▼

Balance sheet in USDView more

NU Skin Enterprises Inc has a Debt to Total Capital ratio of 38.01%, a lower figure than the previous year's 44.14%.
Current ratio1.93
Quick ratio1.20
Total debt/total equity0.6132
Total debt/total capital0.3801
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)3.65%
Div growth rate (5 year)1.33%
Payout ratio (TTM)--
EPS growth(5 years)-39.68
EPS (TTM) vs
TTM 1 year ago
-277.36
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.